CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guangxi Wuzhou Zhongheng Group, Ltd. Company Snapshot
Guangxi Wuzhou Zhongheng Group, Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Wuzhou Zhongheng Group, Ltd. with three other companies in this sector in China: Guilin Sanjin Pharmaceutical Co Ltd (2015 sales of 1.37 billion Chinese Renmimbi [US$198.55 million] of which 96% was Proprietary Chinese medicine), Shanghai Kaibao Pharmaceutical Company Limited (1.40 billion Chinese Renmimbi [US$202.00 million] of which 100% was Industrial), and Jinhe Biotechnology Co Ltd (1.25 billion Chinese Renmimbi [US$180.95 million] of which 90% was Medical Feeds Additives).

Sales Analysis. During the year ended December of 2015, sales at Guangxi Wuzhou Zhongheng Group, Ltd. were 1.34 billion Chinese Renmimbi (US$194.14 million). This is a sharp decrease of 58.2% versus 2014, when the company's sales were 3.21 billion Chinese Renmimbi. The sales level in 2015 was fairly close to the level five years ago: in 2010, Guangxi Wuzhou Zhongheng Group, Ltd. had sales of 1.43 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 71.8% decline in Real Estate, from 85.54 million Chinese Renmimbi to 24.11 million Chinese Renmimbi. There were also decreases in sales in Pharmaceutical Segment (down 59.7% to 1.23 billion Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Food Manufacturing (up 12.4% to 85.75 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guangxi Wuzhou Zhongheng Group, Ltd.
  Stock Performance Chart for Guangxi Wuzhou Zhongheng Group, Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 4.64
(Figures in Chinese Renmimbi)
1 Week 0.7%   13 Weeks -2.7%  
4 Weeks 0.9%   52 Weeks -7.2%  
 
Guangxi Wuzhou Zhongheng Group, Ltd. Key Data:
  Ticker: 600252 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,341,296,773
(Year Ending Jan 2016).
Employees: 2,488
  Currency: Chinese Renmimbi Market Cap: 16,124,497,162
  Fiscal Yr Ends: December Shares Outstanding: 3,475,107,147
  Share Type: A Gu Closely Held Shares: 909,809,804
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.